Prostate Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You are a man aged 40 or older
- You are being seen at Duke Health/Urology and your doctor suspects you may have prostate cancer (but you have not been diagnosed yet)
Who may not be able to join:
- Men who have already been treated for prostate cancer at any point in the past
- Men who have already been diagnosed with prostate cancer
- Men who have a severe and permanent blood-clotting disorder (confirm with trial site)
- Men who are currently taking blood thinners, or who have taken certain blood-thinning or anti-inflammatory medications — including aspirin, ibuprofen, naproxen, diclofenac, clopidogrel, prasugrel, ticagrelor, or dipyridamole — within the 7 days before their blood sample is collected
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: 919-684-5057
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Levels of HeLP™ proteins in the platelets of patients suspected to have PCa; Diagnostic accuracy as reported by area under the curve (AUC)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.